OSNUVO
Google image searchProduct monograph
Active ingredient
teriparatide, 250 MCG/ML
DIN: 02495589
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription / Schedule D
Company: AVIR PHARMA INC.
Date: 27-OCT-2020
ATC:
- H05 — CALCIUM HOMEOSTASIS (ATC, ATC/DDD, )
- H05A — PARATHYROID HORMONES AND ANALOGUES (ATC, ATC/DDD)
- H05AA — Parathyroid hormones and analogues (ATC, ATC/DDD)
- H05AA02 — TERIPARATIDE (ATC/DDD)
Reference brand drug: Forteo, Osnuvo
Pharmaceutical standard: MFR
